One steroid drop, one time for allergic response

Publication
Article
Optometry Times JournalVol. 11 No.7
Volume 11
Issue 7

Athena, our nearly 17-year-old family cat. 

Ben Casella

I have a child with a hypersensitivity to cats. He is 10 years old, and our family cat, Athena, is going on 17 (in human years). Thankfully, my son does not experience anaphylaxis or significant respiratory symptoms from being around her. However, if he pets her and touches one of his eyes before washing his hands, he will have a significant conjunctival response as well as lid hyperemia.

It’s significant enough that I thought I came home from work to a bad case of viral conjunctivitis the first time it happened.

Whoever said you really don’t get to be good at pediatric eye care until you have a child yourself hit the nail on the head with my clinical experience. After limited success with a few ophthalmic allergy medications, I found a quick and easy fix for his encounters with the cat followed by his encounters with his eyeballs.

Previously by Dr. Casella: Everyone tries to figure out health care

One drop, one time
Yes, the first step is prevention, but we all live under the same roof. So, the inevitable does happen, albeit with decreasing frequency, and when it does, he gets a single (one-time) topical steroid drop. Which topical steroid do I prefer? I prefer whichever one is in our medicine cabinet. That’s all he needs. One drop one time, and he’s perfect in about 20 minutes with no rebound flush.

So, with this in mind, I got to thinking not long ago about what I would have done if my son had presented to my clinic as a patient with a significant allergic response to his conjunctiva and corresponding lids. I probably would have put him on a drop (a topical mast cell inhibitor/antihistamine or a topical steroid depending on severity of signs and symptoms) daily until a follow-up visit in five to seven days.

Also by Dr. Casella: I introduce myself to patients as Ben

However, my at-home experience with a family member has proven to me that I’m likely overtreating the patient at least some of the time.

This dichotomy of thought and experience has led me to re-examine my approach to encounters with patients who are suffering a non-chronic hypersensitivity that is confined to the ocular surface without corneal involvement. I learned long ago with topical steroids qid is a low starting dose.

However, maybe I should keep a bottle in my exam room for those few patients who may need a just single dose, then call me in an hour to describe their signs and symptoms. I have successfully followed this model for several years now with my son. Now, if I can get the kids to stop talking about a dog…

Read more editorials here

Recent Videos
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
Nate Lighthizer, OD, FAAO, overviews a handful of YAG laser procedures in his AAOpt presentation.
Susan Gromacki, OD, MS, FAAO, FSLS, details a panel that provided a complete course on keratoconus.
© 2024 MJH Life Sciences

All rights reserved.